Xiangji Ying

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2021 · 440 citations

Medicine, Oncology, Surgery +17

Gastric cancer: Epidemiology, risk factors and prevention strategies

Lei Yang, Xiangji Ying, Shuo Liu et al. · Chinese Journal of Cancer Research · 2020 · 244 citations · Full text

Medicine, Oncology, Preventive Medicine +15

Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

Ziyu Li, Fei Shan, Xiangji Ying et al. · JAMA Surgery · 2019 · 173 citations · Full text

Medicine, Oncology, Surgery +16

Patient-derived tumor-like cell clusters for drug testing in cancer therapy

Shenyi Yin, Ruibin Xi, Aiwen Wu et al. · Science Translational Medicine · 2020 · 102 citations

Medicine, Cancer Biology, Oncology +16

The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy

Ziyu Li, Shuangxi Li, Xiangji Ying et al. · Gastric Cancer · 2020 · 89 citations · Full text

Medicine, Nutrition, Oncology +17